Revelation Biosciences (REVB) Non-Current Assets (2020 - 2026)
Revelation Biosciences (REVB) posted Non-Current Assets of $813,416 for Q2 2026, compared with $35,170 a year earlier and down 3.0% from the prior quarter.
Analysis
Revelation Biosciences (REVB) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Revelation Biosciences' Non-Current Assets came in at $771,296.
- Annual Non-Current Assets shows a five-year compound annual growth rate of -59.8% (FY2020 to FY2025).
- In prior years, Revelation Biosciences' Non-Current Assets was $56,332 in FY2024 (-13.4%), $65,084 in FY2023 (-27.8%), $90,133 in FY2022 (-30.7%) and $130,141 in FY2021 (-99.8%).
- Quarterly Non-Current Assets has run from a low of $23,919 in Q3 2025 to a high of $73.52 million in Q3 2021 over five years.
- On a year-over-year basis, Non-Current Assets increased in 1 of the last five quarters, with an average decline of 33.2%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2024, with growth of 13.9%; the weakest was Q3 2022, with a decline of 99.9%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $838,247 (Q1 2026), $771,296 (Q4 2025) and $23,919 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Revelation Biosciences | 3.36 Mn | -45.66 Mn | - | 813,416.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 813,416.00 |
| Mar 31, 2026 | 838,247.00 |
| Dec 31, 2025 | 771,296.00 |
| Sep 30, 2025 | 23,919.00 |
| Jun 30, 2025 | 35,170.00 |
| Mar 31, 2025 | 42,390.00 |
| Dec 31, 2024 | 56,332.00 |
| Sep 30, 2024 | 81,242.00 |
| Jun 30, 2024 | 70,774.00 |
| Mar 31, 2024 | 77,994.00 |
| Dec 31, 2023 | 65,084.00 |
| Sep 30, 2023 | 71,346.00 |
| Jun 30, 2023 | 77,608.00 |
| Mar 31, 2023 | 83,870.00 |
| Dec 31, 2022 | 90,133.00 |
| Sep 30, 2022 | 96,395.00 |
| Jun 30, 2022 | 102,657.00 |
| Mar 31, 2022 | 108,919.00 |
| Dec 31, 2021 | 130,141.00 |
| Sep 30, 2021 | 73.52 Mn |
API Access
Revelation Biosciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=REVB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();